Takeda gets US nod for Shire buy
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
The FTC’s unconditional clearance of the move “is another significant milestone in the transaction process,” the firm said.
Takeda announced plans to buy Shire in a deal valued at around £46 billion back in May, ranking as one of the industry’s biggest.
Read more: http://www.pharmatimes.com/news/takeda_gets_us_nod_for_shire_buy_1243748
The FTC’s unconditional clearance of the move “is another significant milestone in the transaction process,” the firm said.
Takeda announced plans to buy Shire in a deal valued at around £46 billion back in May, ranking as one of the industry’s biggest.
Read more: http://www.pharmatimes.com/news/takeda_gets_us_nod_for_shire_buy_1243748